This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Henan Medinno Pharmaceutical Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Liang Lu, Pharmaceutical Patent Inventor in Zhengzhou
Introduction
Liang Lu is a male inventor based in Zhengzhou, China. His patent work focuses on pharmaceutical compounds and their potential medical applications. The supplied information credits him with 2 patents.
Latest Patents
One of Liang Lu’s latest patents concerns solid forms of pharmaceutically acceptable salts of a JAK inhibitor. The disclosure describes a compound in solid form, along with related isotopically labeled compounds, isomers, tautomers, salts, prodrugs, and metabolites. It also addresses the compound’s potential use in medicine.
Another patent concerns FGFR inhibitor compounds and their use. It describes a compound represented by formula (I), including related labeled compounds, isomers, tautomers, pharmaceutically acceptable salts, prodrugs, and metabolites, and discusses their potential medical applications.
Career Highlights
The supplied career information associates Liang Lu with Henan Medinno Pharmaceutical Technology Co., Ltd. and Medinno Pharmaceutical Technology (Zhuhai) Co., Ltd. His listed patent portfolio reflects work on compounds targeting JAK and FGFR pathways.
Collaborations
Liang Lu’s listed coworkers include Saisai Zhao and Jixuan Zhang. Their names are associated with his pharmaceutical patent work in the information provided.
Conclusion
Liang Lu’s reported inventions focus on pharmaceutical compounds and their potential therapeutic uses, with patent activity spanning JAK and FGFR inhibitors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile